BLTG.L Regulatory News (BLTG)

10 May 2012

Regenersis plc

("Regenersis" or the "Company")

Director/PDMR Shareholding

Regenersis plc (the 'Company'), a strategic outsourcing partner to many of the world's leading consumer technology companies, received notification on 10 May 2012 of the following director dealing in the ordinary shares of 2 pence each in the Company ("Shares").

On 8 May 2012, Hanover Investment Partners - IX LLC acquired 800,000 Shares. The purchase price of these shares was 100 pence per Share.

Matthew Peacock, Chairman of Regenersis, as a partner in Hanover Investors Management LLP, has an indirect beneficial interest in these shares. The combined resultant holding of Hanover Investors Management LLP and its connected parties is 9,838,351 ordinary shares equating to 21.95 per cent. of the issued share capital of the Company.

Enquiries:

Ends